Rahul Banerjee, MD, FACP
@RahulBanerjeeMD
Followers
11K
Following
62K
Media
2K
Statuses
31K
Asst Professor @UWMedicine @fredhutch. Goals: improve pt experience in myeloma #MMsm: ⬇️ dex, ⬆️ time at home, 📱-based wellness. COI: https://t.co/3Uuojuio6R
Seattle, WA
Joined March 2009
Grateful to @BloodJournal, co-authors, and @SWOG for making this #downwithdex piece possible!. Dex 40mg weekly in #MMsm induction:. 1️⃣ Not practical even for trial-enrolled patients.2️⃣ Does not improve PFS vs ⬇️ dex. Twitter 🧵 once I’m back from #IMS24!.
#Myeloma Paper of the Day: Cool paper from @RahulBanerjeeMD showing analysis of S0777 and S1211 @SWOG trial data that lowering the dose of dex during induction therapy did not have an impact on long-term outcomes like PFS & OS: #mmsm
20
43
179
RT @JADPRO: Federal funding cuts have terminated over 2,000 NIH grants and dozens of clinical trials. @Bethfaiman highlights how these chan….
0
2
0
RT @jitcancer: New #JITC article: Comparison of axicabtagene ciloleucel and tisagenlecleucel patient CAR-T cell products by single-cell RNA….
0
3
0
RT @NEJM: Measurable residual disease (MRD) is a major prognostic factor in newly diagnosed multiple myeloma. Whether MRD-guided consolidat….
0
17
0
RT @IMFmyeloma: Being a care partner can be challenging, but you are not alone. Check out the IMF's new Care of the Care Partner Tip Card t….
0
1
0
RT @VJHemOnc: GPRC5D-directed therapies are reshaping the #MultipleMyeloma treatment landscape.🩸. Explore practical considerations with the….
0
5
0
RT @TheMarkFdn: Could the same proteins that drive autoimmune disease help fight cancer?. In @Nature, Emerging Leader Award winner @aaronmr….
0
3
0
RT @medicalwatchBC: @NicoGagelmann @bdermanmd @VincentRK @RahulBanerjeeMD 5/ @Abdallah81MD on China and cellular therapy innovation: https:….
0
2
0
RT @medicalwatchBC: @NicoGagelmann @bdermanmd @VincentRK 4/ @RahulBanerjeeMD on predicting bsAb efficacy in MM:.
0
1
0
RT @Blood_Cancers: Don't miss the latest episodes of your favorite podcast!. @GKaurMD, @DimaDanai, @LymphClinician, Amir Fathi, and more re….
0
3
0
RT @MostafaFaisal14: Sequential Targeting in Multiple Myeloma: Talquetamab, a GPRC5D bispecific antibody, as a Bridge to BCMA CAR-T cell th….
ashpublications.org
Key Points. Talquetamab bridging is feasible, safe and effective allowing rapid disease control with minimal grade toxicity.Talquetamab enabled transition
0
3
0
RT @majorajay: Day 1 of @ASH_hematology CRTI! Super excited to learn from all these phenomenal investigators and faculty this week. #hemetw….
0
2
0
RT @IMFmyeloma: #Seattle: Connect with the #myeloma community, build your support network, ask the experts your questions, find support in….
0
2
0
RT @drshrinidhi2020: Dynamic ctDNA Monitoring: A Primary Tool Predictive of Response in a Patient on CAR‐T Cell Therapy - Rahul - 2025 - In….
onlinelibrary.wiley.com
Introduction Dynamic monitoring of circulating tumor DNA (ctDNA) offers a non-invasive method to track treatment response in malignancies. While well-established in solid tumors, its role in lympho...
0
4
0
RT @HadidiSamer: Check my editorial @BloodPortfolio #mmsm @UAMSMyeloma : Time-tested safety: FCARH143’s 5-year myeloma journey. Free access….
0
8
0
RT @Abdallah81MD: 3/⚖️ Flexible Regulations.With fewer bureaucratic hurdles, trials in China get approved quicker. Think speed over red tap….
0
1
0
RT @Abdallah81MD: 1/🇨🇳💥 Why I believe China is bypassing the U.S. in cellular therapy innovation (CAR-T, gene editing, etc.):.A thread 🧵👇….
0
11
0
RT @Abdallah81MD: 🧠💉 Management Recommendations for Kidney Transplantation in Patients with Plasma Cell Dyscrasia — a much-needed read!. Wh….
0
8
0
Fascinating 🐁-model work in @NatureComms - BCMA isn’t as essential to plasma cell function as we thought. Might just exist to modulate APRIL-TACI binding!. Of course human biology different, and APRIL CAR (which also targets TACI) results disappointing… but food for thought!
B cell maturation antigen (BCMA) is dispensable for the survival of long-lived plasma cells @NatureComms .
3
4
18
RT @LabWaggoner: B cell maturation antigen (BCMA) is dispensable for the survival of long-lived plasma cells @NatureComms ..
0
16
0